Biotech news
Americas
US-based biopharmaceutical company AbbVie entered into a patent licensing agreement with generics company Mylan yesterday. 18 July 2018
Americas
A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company. 18 July 2018
Americas
Josh Makower, partner at venture capital investor New Enterprise Associates, explains to LSIPR the firm’s role in supporting medtech innovation, his sweet spot when it comes to projects, and how to balance what is medically relevant with commercial viability. 17 July 2018
Americas
In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports. 17 July 2018
Pharma
While the UK’s pharmaceutical and biotech industries have welcomed the government’s latest White Paper on Brexit, a number of uncertainties remain, according to lawyers. 16 July 2018
Biotech
As the Broad Institute faces a formidable task in defending its revoked CRISPR patent claims in a pending appeal at the EPO, European academics Jakob Wested, Timo Minssen, and Esther van Zimmeren are wondering whether some of the issues might be referred to the Enlarged Board of Appeal. 13 July 2018
Americas
A former employee pleaded guilty to stealing trade secrets from what is now the world’s largest chemicals company earlier this week. 13 July 2018
Biotech
Europol has seized 360 tonnes of counterfeit or illegal pesticides across Europe over the course of 20 days, in what the agency has deemed its largest-ever haul of fake pesticides. 12 July 2018
Americas
Scott Alban of AstraZeneca outlines the company’s recent transformation aimed at breaking down barriers and the uncharted territories that it is eager to explore. 12 July 2018
Americas
King & Spalding has boosted its IP practice with two new partners in its trial and global disputes practice group in New York. 10 July 2018